Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125501631 | 12550163 | 1 | I | 20160706 | 20160712 | 20160712 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201607002020 | ELI LILLY AND CO | 52.00 | YR | F | Y | 0.00000 | 20160712 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125501631 | 12550163 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 500 MG/M2, UNK | U | 21462 | 500 | MG/M**2 | INJECTION | ||||||
| 125501631 | 12550163 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | 75 MG/M2, UNK | 0 | 75 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125501631 | 12550163 | 1 | Peritoneal mesothelioma malignant |
| 125501631 | 12550163 | 2 | Peritoneal mesothelioma malignant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125501631 | 12550163 | DE |
| 125501631 | 12550163 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125501631 | 12550163 | General physical health deterioration | |
| 125501631 | 12550163 | Haematotoxicity | |
| 125501631 | 12550163 | Ileus paralytic | |
| 125501631 | 12550163 | Malignant neoplasm progression | |
| 125501631 | 12550163 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |